Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence.

Current Biology : CB
Joseph A KimJennifer L Whistler

Abstract

Opioid drugs, such as morphine, are among the most effective analgesics available. However, their utility for the treatment of chronic pain is limited by side effects including tolerance and dependence. Morphine acts primarily through the mu-opioid receptor (MOP-R) , which is also a target of endogenous opioids. However, unlike endogenous ligands, morphine fails to promote substantial receptor endocytosis both in vitro, and in vivo. Receptor endocytosis serves at least two important functions in signal transduction. First, desensitization and endocytosis act as an "off" switch by uncoupling receptors from G protein. Second, endocytosis functions as an "on" switch, resensitizing receptors by recycling them to the plasma membrane. Thus, both the off and on function of the MOP-R are altered in response to morphine compared to endogenous ligands. To examine whether the low degree of endocytosis induced by morphine contributes to tolerance and dependence, we generated a knockin mouse that expresses a mutant MOP-R that undergoes morphine-induced endocytosis. Morphine remains an excellent antinociceptive agent in these mice. Importantly, these mice display substantially reduced antinociceptive tolerance and physical dependence. These ...Continue Reading

References

May 1, 1995·Anesthesiology·A Duttaroy, B C Yoburn
Aug 9, 1996·The Journal of Biological Chemistry·D E KeithM von Zastrow
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·C SterniniN C Brecha
Sep 25, 2001·Neuroreport·C Abbadie, G W Pasternak
Dec 26, 2001·Molecular Pharmacology·T BushellR J Miller
Jun 7, 2005·Current Biology : CB·Li He, Jennifer L Whistler
Jun 28, 2005·British Journal of Pharmacology·Elena E BagleyMark Connor
Mar 31, 2006·Psychopharmacology·Gisela GreckschThomas Koch

❮ Previous
Next ❯

Citations

Sep 29, 2011·Cellular and Molecular Neurobiology·Jia-Ming BianJin Li
Jan 8, 2009·Current Pain and Headache Reports·Jodie A Trafton, Abhinav Ramani
Apr 20, 2013·Trends in Biochemical Sciences·Ping-Yee LawHorace H Loh
Aug 22, 2009·Nature Reviews. Molecular Cell Biology·Alexander Sorkin, Mark von Zastrow
Jun 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ajay RavindranathanRaymond L White
Mar 2, 2010·The Journal of Biological Chemistry·Paola MolinariTommaso Costa
Oct 22, 2008·The Journal of Biological Chemistry·Michael TanowitzMark von Zastrow
Mar 29, 2013·Molecular Biology of the Cell·Amanda L Soohoo, Manojkumar A Puthenveedu
Dec 24, 2011·British Journal of Anaesthesia·N DietisD G Lambert
Aug 15, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Li HeJennifer L Whistler
May 13, 2011·The Journal of Pharmacology and Experimental Therapeutics·Johan EnquistJennifer L Whistler
Nov 9, 2011·The Journal of Pharmacology and Experimental Therapeutics·Johan EnquistJennifer L Whistler
Jan 17, 2013·Pharmacological Reviews·John T WilliamsMacdonald J Christie
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Joël BockaertLaurent Fagni
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anuradha MadhavanJennifer L Whistler
Dec 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Amynah A A PradhanBrigitte L Kieffer
Mar 6, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anuradha MadhavanJennifer L Whistler
Sep 3, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Y Joy YuMark von Zastrow
Jun 10, 2011·EMBO Molecular Medicine·Amy Chang Berger, Jennifer L Whistler
Apr 4, 2012·Expert Opinion on Drug Discovery·Mellar P Davis
Sep 20, 2011·Trends in Pharmacological Sciences·Amynah A PradhanBrigitte L Kieffer
Oct 2, 2009·Peptides·Richard J Bodnar
Oct 22, 2008·Life Sciences·Yulin WangLee-Yuan Liu-Chen
Sep 22, 2010·Traffic·James N Hislop, Mark von Zastrow
Jul 2, 2011·British Journal of Pharmacology·J KarglM Waldhoer
May 14, 2011·British Journal of Pharmacology·Vu C Dang, MacDonald J Christie
Jun 20, 2012·British Journal of Pharmacology·Amynah A PradhanChristopher J Evans
May 4, 2010·Annals of Neurology·Amy Chang Berger, Jennifer L Whistler
May 14, 2014·British Journal of Pharmacology·E W OngC M Cahill
Mar 29, 2014·British Journal of Pharmacology·T A MaceyS L Ingram
Jan 8, 2015·Frontiers in Pharmacology·Stéphane AlloucheNicolas Marie
Apr 29, 2010·Molecular Pharmacology·Hans Jürgen SolinskiAndreas Breit
Feb 17, 2018·Neural Regeneration Research·Juhwan KimChangjong Moon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.